There is, however, a requisite for further inquiries to unravel the intricate mechanistic roles of USP14 and FABP5 in the oncogenic evolution of HNSCC and to ascertain their viability as therapeutic targets. This evidence concerns the gene FABP5 and head and neck squamous cell carcinoma.